Strategies to improve safety profile of AAV vectors.

Front Mol Med · 2022 · PMC11285686 · PMID 39086961

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

might be significantno p-value reported

Interestingly, another co-immunoprecipitation study with AAV6 found no specific complement binding ( Denard et al., 2013 ), suggesting that once again the differences between the different serotypes might be significant.

also in 2,435 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.